Clinical Trials Directory

Trials / Completed

CompletedNCT03236454

tDCS-enhanced Working Memory Training in Subjective Cognitive Decline

Effects and Mechanisms of Cognitive Control Training Combined With Transcranial Direct Current Stimulation (tDCS) in Subjective Cognitive Decline.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
University Hospital Tuebingen · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Accepted

Summary

This 2-armed randomized, sham-controlled, single-blind study aims at providing evidence for the efficacy of a transcranial direct current stimulation (tDCS)-enhanced cognitive control training (PASAT) in participants with subjective cognitive decline (SCD). Overall, the study will include 30 participants. Each participant will take part in a four weeks training (12 sessions); 50% of the participants will receive 2mA anodal tDCS for 20 minutes applied to the left dorsolateral prefrontal cortex (dlPFC), the other half will receive sham stimulation. Event-related potentials (ERPs) evoked by the feedback on the correctness of the response at baseline and after training will be measured with EEG as neurophysiological signatures of cognitive control. Near and far transfer will be assessed by a verbal 2-back task and the Trail Making Test A and B. The amount of worrying regarding the memory impairment will be quantified by means of a 10 point Likert-Scale. Together with changes of PASAT performance these measures will be obtained before and after the tDCS-enhanced training. Follow-up assessments 3, 12 and 24 months after training will investigate the stability of training effects.

Conditions

Interventions

TypeNameDescription
DEVICEDC-Stimulator MC, NeuroConn20 minutes of 2 mA anodal stimulation; Electrode placement: left dorsolateral prefrontal cortex (F3, EEG 10/20 system), return electrode at the right upper arm.

Timeline

Start date
2017-05-11
Primary completion
2017-09-30
Completion
2020-01-01
First posted
2017-08-02
Last updated
2020-01-13

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03236454. Inclusion in this directory is not an endorsement.